SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson Disease

Clinical trial NCT00335166 · COMPLETED

Trial details

NCT number: NCT00335166
Sponsor: Solvay Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Early Stage Parkinson Disease

Start date: 2006-11-01
Primary completion: 2008-02-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.